MX9604553A - Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion. - Google Patents

Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion.

Info

Publication number
MX9604553A
MX9604553A MX9604553A MX9604553A MX9604553A MX 9604553 A MX9604553 A MX 9604553A MX 9604553 A MX9604553 A MX 9604553A MX 9604553 A MX9604553 A MX 9604553A MX 9604553 A MX9604553 A MX 9604553A
Authority
MX
Mexico
Prior art keywords
treatment
low dosage
disorders associated
gastrointestinal disorders
acid secretion
Prior art date
Application number
MX9604553A
Other languages
Spanish (es)
Other versions
MXPA96004553A (en
Inventor
Alan Bye
Jill Evans
Paul Derrick Huckle
Laurence Francis Lacey
John Peter Rue
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MX9604553A publication Critical patent/MX9604553A/en
Publication of MXPA96004553A publication Critical patent/MXPA96004553A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to low dosage formulations containing the histamine H2-receptor antagonist ranitidine and their use in the treatment of gastric disorders such as episodic heartburn.
MXPA/A/1996/004553A 1994-04-12 1996-10-03 Compositions of dosing ranitidine b MXPA96004553A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9407235.2 1994-04-12
GB9407235A GB9407235D0 (en) 1994-04-12 1994-04-12 Pharmaceutical compositions
PCT/EP1995/001271 WO1995027486A1 (en) 1994-04-12 1995-04-10 Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion

Publications (2)

Publication Number Publication Date
MX9604553A true MX9604553A (en) 1997-11-29
MXPA96004553A MXPA96004553A (en) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
BR9507312A (en) 1997-10-07
CN1146150A (en) 1997-03-26
EP0755251A1 (en) 1997-01-29
AU2138095A (en) 1995-10-30
NZ283354A (en) 1998-08-26
GB9407235D0 (en) 1994-06-08
WO1995027486A1 (en) 1995-10-19
AU690664B2 (en) 1998-04-30
ZA952931B (en) 1996-01-05
CA2187651A1 (en) 1995-10-19
JPH10502331A (en) 1998-03-03
KR970702034A (en) 1997-05-13

Similar Documents

Publication Publication Date Title
AP2001002088A0 (en) 4,4-Biarylpiperidine derivatives with opiod receptor activity.
PL300194A1 (en) Interferon conjugate, method of obtaining same and pharmaceutical composition containing it
EP0935417A4 (en) Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
IL152659A (en) Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer
MY133393A (en) Phenyl xanthine derivatives
YU20003A (en) Fused heterocyclic succinamide compounds and analogs thereof, modulators of nuclear hormone receptor function
NZ247201A (en) Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions
ZA937544B (en) Pharmaceutical compositions
IE940326L (en) Benzimidazole derivatives substituted with a radical group¹and their use for inhibiting gastric acid secretion
GR82243B (en)
ZA943744B (en) Therapeutic substituted guanidines
WO2000011000A3 (en) New compounds
SE9401197D0 (en) Active compounds
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
WO2000010999A3 (en) New compounds
WO1996022305A3 (en) Modified peptides
MX9701187A (en) Novel n-substituted naphthofused lactams.
DE3479290D1 (en) Synergistic composition comprising gamma interferon and lymphotoxin, and its preparation
IL67940A0 (en) 2,3-diaryl-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them
BG103306A (en) Liquid allendronate compositions
MX9604553A (en) Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion.
UA42722C2 (en) Sulphides, sulphoxides and sulphones or the pharmaceutically acceptable salts thereof and pharmaceutical composition containing them
SI1196129T1 (en) Pharmaceutical and cosmetic compositions comprising urocanic acid derivatives as radical scavengers or antioxidants
ES8105975A1 (en) Carbamates, their preparation and pharmaceutical compositions containing them.